Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2010
03/11/2010US20100063010 Method for administering a spill resistant pharmaceutical system
03/11/2010US20100062064 Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
03/11/2010US20100062058 Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same
03/11/2010US20100062048 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
03/11/2010US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
03/11/2010CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010CA2735795A1 Novel inhibitors
03/11/2010CA2735714A1 Treatment of neonate foals with meloxicam
03/11/2010CA2735521A1 Indolizine inhibitors of leukotriene production
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/11/2010CA2734682A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
03/11/2010CA2734527A1 Novel compounds as cannabinoid receptor ligands
03/11/2010CA2733671A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010CA2733249A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP2161282A1 Peptide analogues of PACAP
03/10/2010EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
03/10/2010EP2161262A1 THCV and THCV extracts derived from plant material
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010EP2160393A1 Novel compounds as cannabinoid receptor ligands
03/10/2010EP2160386A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
03/10/2010EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1841423B1 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides and related compounds as analgesics
03/10/2010EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors
03/10/2010EP1605964B1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
03/10/2010EP1423376B1 Bicyclic compound, production and use thereof
03/10/2010EP1313699B1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
03/10/2010EP1114061B1 FACTOR VIIa INHIBITORS
03/10/2010CN101664545A Therapies for renal failure using interferon-beta
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/09/2010US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674789 Compounds
03/09/2010US7674788 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2411922C Composition for pain mediation and apparatus and method of use thereof
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2306313C Dipeptide nitriles
03/04/2010WO2010025430A2 Homeopathic therapeutic method
03/04/2010WO2010025202A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF
03/04/2010WO2010025201A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases.
03/04/2010WO2010025138A2 Pyrimidine compounds
03/04/2010WO2010025073A1 Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010024226A1 Prophylactic or therapeutic agent for bone/joint diseases comprising, as active ingredient, pyrrole derivative having ureide group, aminocarbonyl group and substituted phenyl group as substituents
03/04/2010WO2010023908A1 Nanocapsules containing indomethacin and manufacturing method therefor
03/04/2010WO2010023448A1 Novel potassium channel blockers
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010WO2010023422A1 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
03/04/2010WO2009143292A9 Method of treating pneumoconiosis with oligodeoxynucleotides
03/04/2010WO2009129491A3 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
03/04/2010WO2009129147A4 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
03/04/2010WO2009087005A4 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010WO2009003284A8 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
03/04/2010US20100056632 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
03/04/2010US20100056615 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
03/04/2010US20100056613 Spiroquinone compound and pharmaceutical composition
03/04/2010US20100056599 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids
03/04/2010US20100056558 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors
03/04/2010US20100056554 Use of opioid formulations in needle-less drug delivery devices
03/04/2010US20100056548 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
03/04/2010US20100056532 Compounds that modulate intracellular calcium
03/04/2010US20100056528 Sulfonamide derivatives with therapeutic indications
03/04/2010US20100056512 Pyrimidine compounds
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100055176 Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
03/04/2010US20100055160 Analgesic anti-inflammatory patches for topical use
03/04/2010US20100055103 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010US20100055101 Cytokine receptor zcytor17 multimers
03/04/2010US20100055093 Pan-cell surface receptor-specific therapeutics
03/04/2010US20100055092 Preventive or Remedy for Inflammatory Disease
03/04/2010US20100055048 Acute treatment of headache with phenothiazine antipsychotics
03/04/2010CA2734502A1 Homeopathic therapeutic method
03/04/2010CA2724766A1 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
03/03/2010EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/03/2010EP2158905A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158904A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158318A2 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
03/03/2010EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
03/03/2010EP1389183B1 Sulfonamide derivatives
03/03/2010CN101658486A Hydrous external preparation containing sodium loxoprofen
03/03/2010CN100592909C Dosage form of sodium ibuprofen
03/02/2010US7671252 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
03/02/2010US7671090 Inhibitors of α4 mediated cell adhesion
03/02/2010US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671071 Crystal structure; antihistamines; histamine H1-antagonists; side effect reduction; storage stability
03/02/2010US7670791 regulating an alpha 1G T-type calcium channel in the central nervous system and alpha 1H and alpha 1I T-type calcium channels in the peripheral nervous system; analegesic
03/02/2010US7670618 Pharmaceutical compositions
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 1272